Top Industry Leaders in the America Blood Glucose Monitoring Market
Abbott Introduced the FreeStyle Libre 3 system, a continuous glucose monitoring (CGM) device offering improved sensor wear time and accuracy, targeting both type 1 and type 2 diabetic patients.
Dexcom Received FDA approval for its G7 CGM system, featuring enhanced sensor performance and extended wear time, aiming to further simplify diabetes management for users.
Medtronic Launched the Guardian 4 CGM system with new features like optional glucose alerts and on-demand glucose readings, aiming to provide broader access to CGM benefits.
Roche: Announced positive Phase 3 data for its Accu-Chek Guide System, a next-generation BGM system with an integrated insulin calculator, potentially simplifying management for type 2 diabetes patients.
List of Americas Blood Glucose Monitoring Key Companies in the Market
- Abbott Laboratories (US)
- Arkay Inc. (US)
- Dexcom Inc. (US)
- LifeScan Inc. (US)